Skip to NavigationSkip to content


MRI scans can help predict MS patient’s long term prognosis, 15 year study shows

MRI scans can predict MS patient’s long term prognosis when they are first diagnosed, according to new research.

In a 15 year study published in the journal Brain, information collected from magnetic resonance imaging (MRI) scans was shown to be able predict long term disease outcomes.

The study, saw researchers look at predictors of key long-term outcomes in 178 patients with clinically isolated syndrome (CIS), a condition in which many patients go on to develop MS.

New diagnostic tool predicts tuberculosis infection with 73% accuracy

A new diagnostic technology has demonstrated the ability to identify human tuberculosis (TB) infection and those at highest risk of developing the disease with high levels of accuracy.

PBD Biotech’s Actiphage assay is marketed as a test for detecting TB and Johne’s disease in cows via a blood or milk test, but has shown in clinical trials to also be very effective in human diagnosis.

Stanford scientists develop test for ME

Scientists from Stanford University have, for the first time, developed a test for Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).

The blood test offers new evidence for the biological basis of ME, which has been controversial for many years.

“Too often, this disease is categorized as imaginary,” said Dr Ron Davis, professor of biochemistry and of genetics.

The test, which scientists say diagnoses ME with 100% accuracy, uses a nanoelectronic assay to test changes in electrical activity in immune cells in blood plasma.

Nearly half of childhood cancer cases go untreated and undiagnosed

Almost half of all children with cancer are going untreated and undiagnosed, according to research published in Lancet Oncology.

While just 3% of childhood cancer cases in Western Europe and North America are thought to have been missed in 2015, 49% of cases in South Asia and 57% of cases in West Africa went undiagnosed.

Living with fibular hemimelia

Published on 08/11/18 at 04:14pm

Helena Baker, Vice President of Clinical Strategy at Medical Research Network and a trustee of the newly formed Rare Disease Nurse Network, was born with fibular hemimelia, a rare condition characterised by a congenital absence of the fibula bone, but went undiagnosed for almost half a century. She’s shares how her experience has shaped her life and her work to help others affected by rare disease

Can you tell us a bit about your condition and how you came to be diagnosed?

Half of kidney cancer patients initially misdiagnosed

Half of kidney cancer patients are initially misdiagnosed, according to data from Kidney Cancer UK’s patient survey.

Despite being the 7th most common cancer in the United Kingdom, 45% of patients were initially treated for less serious conditions such as urine infections, kidney stones or respiratory problems.

Meanwhile 48% of patients are already at the most advanced form of the disease, stage III or IV, before they receive a diagnosis.

Notably only 5% of patients at stage IV will survive beyond five years.

Widening the focus on innovations in cancer treatment

Published on 03/09/18 at 11:56am

Cancer treatment is making leaps and bounds, but public focus tends to gravitate towards the therapies themselves. Matt Fellows explores other areas where innovation is creating better patient outcomes.

Much has already been said on the advances of cancer treatment, and with much excitement. Rightfully so, as the rise of immuno-oncology blockbusters such as Bristol-Myers Squibb’s Opdivo and MSD’s Keytruda continue to dominate the market and rack up an ever-growing list of approved indications around the globe.

Bill Gates commits $30m towards Alzheimer's diagnostic test

Microsoft business magnate Bill Gates has joined a coalition of philanthropists in committing more than $30 million towards the development of an Alzheimer’s diagnostic test.

Gates joins former Estée Lauder chief Leonard Lauder, the Dolby Family and the Charles and Helen Schwab foundation, among others, in donating towards the launch of the Diagnostic Accelerator which aims to develop a “reliable, affordable, and accessible” diagnostic test for the neurodegenerative disease.

Westminster Health Forum Keynote Seminar - Cardiovascular Diseases: commissioning, innovation, patient experience and outcomes

Mission Statement is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches